Introduction
============

Veterans of the Vietnam War have higher rates of medical and psychiatric comorbidities than similarly aged non-veterans.[@b1-nss-6-123] Sleep disordered breathing (SDB), as defined by the National Institutes of Health (<http://www.nhlbi.nih.gov>) describes a group of disorders characterized by abnormalities of respiratory pattern (pauses in breathing) or the quantity of ventilation during sleep. Obstructive sleep apnea (OSA), the most common such disorder, is characterized by the repetitive collapse or partial collapse of the pharyngeal airway during sleep and the need to arouse to resume ventilation. Previous work has demonstrated a prevalence of SDB of approximately 60% in Vietnam War veterans with post-traumatic stress disorder (PTSD), and with high rates of obesity.[@b2-nss-6-123],[@b3-nss-6-123] In a study comparing veterans with PTSD to veterans without PTSD, 82% of those with PTSD were overweight, obese, or morbidly obese.[@b4-nss-6-123] The average body mass index (BMI) of Vietnam War veterans with PTSD has been estimated to be 30.5±5.9 kg/m^2^.[@b4-nss-6-123] These comorbidities appear to place Vietnam veterans at an increased risk of cognitive decline.[@b5-nss-6-123] However, no data are currently available on the stability of SDB or obesity in these populations, or on the longitudinal relationships of these conditions and cognition. A better understanding of these conditions is necessary to develop effective countermeasures. Using data from the PTSD Sleep Apnea Clinical Study, we examined the trajectory of SDB, obesity and cognition in Vietnam veterans with PTSD. Given the relationship between each of these conditions, we hypothesized that the conditions would follow similar trajectories over the 3-year period.

Methods
=======

Participants
------------

Forty-eight participants were selected from a cohort of community-dwelling male veterans aged 55 years or older who were recruited into a study of the effects of PTSD, sleep apnea, and cognition.[@b2-nss-6-123],[@b3-nss-6-123] Recruitment methods included media advertisement, contact with local veteran agencies, and clinician referral from the outpatient clinics of Veterans Affairs (VA) Palo Alto Health Care System (VAPAHCS). The 48 participants selected for this analysis completed annual assessments over a 3-year period. Informed consents, approved by Stanford University and VAPAHCS Institutional Review Boards, were obtained from all participants.

The presence of PTSD was determined by the Clinician Administered PTSD Scale for *Diagnostic and Statistical Manual, Fourth Edition* (DSM-IV) (CAPS),[@b6-nss-6-123] with the entry criteria of a CAPS current and/or lifetime score ≥40. Participants were excluded if they: 1) had a current or lifetime history of any other psychiatric disorder with primary psychotic features or symptoms that met the DSM-IV as determined by the *Structured Clinical Interview for DSM-IV TR Axis I Disorders, Research Version, Non-patient Edition. (SCID-I/NP)*;[@b7-nss-6-123] 2) had a current or recent exposure to trauma in the past 3 months (chart review, interview); 3) met DSM-IV criteria for drug and/or alcohol abuse or dependence (except nicotine) within the last 30 days as determined by the SCID;[@b7-nss-6-123] 4) were alcohol intoxicated (by breathalyzer), in alcohol withdrawal (by physical exam) during testing, or exhibited toxicology evidence of illicit substance use prior to exam (72-hour metabolite toxicology screen); 5) showed evidence of probable or possible dementia (Mini-Mental State Examination[@b8-nss-6-123] score of \<23); 6) reported a history of seizure or other neurologic disorder or system illness affecting central nervous system function (chart review, interview); 7) suffered a head injury within 1 year or had a history of loss of consciousness \<24 hours or; 8) used systemic steroid medication (with the exception of estrogen replacement therapy). Participants were not recruited on the basis of presence or absence of sleep or SDB complaints.

Patients were informed of a suspected SDB finding when the Apnea-Hypopnea Index (AHI) was ≥10. Referral to Pulmonary Medicine specialist was facilitated. At baseline, seven subjects reported a prior apnea diagnosis but only two were using continuous positive airway pressure (CPAP) machines. At the final visit, the number of subjects using CPAP had increased to 13, of which only five reported nightly use.

Measures
--------

Cognitive assessments and overnight polysomnography were performed by trained clinicians or technicians.

### Body mass index

BMI was determined by VA staff using the standard formula (weight in pounds ×703)/(height in inches)[@b2-nss-6-123].

### Polysomnography

SDB was assessed using unattended, overnight polysomnography (Safiro Ambulatory Polysomnography System; Compumedics USA Inc., Charlotte, NC, USA). The data were scored for sleep staging and respiratory events by a registered polysomnographic technologist[@b9-nss-6-123] and were reviewed by a diplomat of the American Board of Sleep Medicine (Dr Cheng). The primary outcome measure was the AHI, a descriptor of the severity of SDB. Respiratory events were defined as cessation (apnea) or discrete reduction (hypopnea) in airflow or chest wall impedance, lasting at least 10 seconds and associated with oxygen desaturation level of at least 3%. The AHI represents "the number of apneas and hypopneas divided by the number of hours of sleep".[@b10-nss-6-123] All subjects with clinically significant SDB (defined as AHI ≥10) agreed to have their primary medical doctors notified of this finding. Mean pulse oximeter oxygen saturation (mean SpO~2~) was also measured during polysomnography.

### Cognitive assessments

Auditory verbal memory was assessed with the Rey Auditory Verbal Learning Test (RAVLT).[@b11-nss-6-123] The RAVLT is a reliable and valid measure of verbal learning and memory. Note that a higher RAVLT score indicates higher levels of cognitive functioning. For the purposes of these analyses, we used the sum of trials I through V of the RAVLT.

Executive function was assessed with the Color-Word Interference Test (CWIT) from the Delis--Kaplan Executive Function System battery.[@b12-nss-6-123] For this study, we used a CWIT time score, which was calculated by subtracting the average time it took each participant to complete the color and word naming tasks from the time it took each participant to complete the CWIT \[interference time -- ((color-naming time + word-naming time)/2)\]. Higher CWIT scores indicate lower levels of cognitive functioning.

Statistical analyses
--------------------

We used mixed effects modeling to examine the change in the variables of interest (ie, AHI, BMI, and cognition) over the 3-year period. Estimation of our model was performed using the SAS PROC MIXED procedure, version 9.3 (SAS Institute, Cary, NC, USA). In the analysis of our primary outcome measure, AHI was the dependent variable and year (0, 1, 2, or 3) was the predictor. In our secondary analyses, we ran three additional mixed models where BMI, the sum of trials I through V of the RAVLT, and the CWIT time score were dependent variables, with year as the predictor variable for each model.

Results
=======

[Table 1](#t1-nss-6-123){ref-type="table"} contains a description of our sample of Vietnam War era veterans. All are male, and the prevalence of SDB was 60% using a criterion of AHI ≥10/hour. Seventy-three percent of our sample was non-Hispanic, and the same percentage was Caucasian.

[Table 2](#t2-nss-6-123){ref-type="table"} contains the yearly mean AHI, mean SpO~2~, BMI, RAVLT, and CWIT scores, along with standard deviations and standard errors, minimums and maximums. Based on the model, AHI increased significantly by 2.19 points per year (β=2.19; *P*\<0.005). AHI worsened over the 3-year period, increasing from a mean of 18.7±15.7 points to 24.7±17.4 points. [Figure 1](#f1-nss-6-123){ref-type="fig"} shows the change of AHI over time with corresponding standard errors. Analysis of other outcomes of interest (ie, BMI and cognitive function) revealed no significant change over the 3-year period (*P*-values ≥0.20).

Discussion
==========

This study examined the 3-year trajectory of SDB, BMI, and cognitive function in a sample of older Vietnam War era veterans diagnosed with PTSD. Prior work has demonstrated high prevalence rates of both SDB and obesity in this population.[@b2-nss-6-123],[@b3-nss-6-123] While SDB was found to worsen significantly over the 3-year period, no significant change was seen in cognitive function or BMI.

In light of prior work demonstrating the negative impact that SDB has on cognition,[@b5-nss-6-123] the stability of cognitive functioning in the presence of worsening SDB was surprising. This observation may be due to the fact that the duration of follow-up may not have been sufficient to document change in non-demented individuals.

The stability of BMI is similar to what has been reported in other studies of older adults.[@b13-nss-6-123] Current military personnel with PTSD also seem to suffer from an increased incidence of SDB and obesity. A recent study of 110 military personnel returned from deployment found that within 18 months of deployment, 62.7% met diagnostic criteria for OSA and had a mean BMI of 30.0±4.3 kg/m^2^.[@b14-nss-6-123] Thus the prevalence of 60% found in our veterans is similar to that reported in recently deployed military personnel.

Prior cross-sectional epidemiological work has shown that the prevalence of sleep apnea tends to increase with age but the clinical significance (severity) of apnea appeared to decrease.[@b15-nss-6-123] This is distinct from our current longitudinal work that shows an increase in apnea severity. One possible explanation is that subjects with the most severe apnea die at earlier ages and have not been sampled when they reached an old age, thus falsely implying a reduction of apnea symptoms in older cohorts. Although our subjects were followed for 3 years, longer follow-up would provide better mortality data.

SDB is widely accepted as having significant negative effects on health status. Our findings demonstrate that over a 3-year period, SDB was found to significantly worsen. This worsening occurred at a time of life in which there is an increased risk of cognitive impairment. Given the high prevalence rate of AHI in this sample, coupled with the increased severity of SDB symptoms over time, it is important for providers to regularly assess for SDB in veterans. Further analysis of participant characteristics in the current sample is limited due to the small sample size, thus the importance of future research with larger samples. Finally, successful treatment of SDB is challenging in civilians.[@b16-nss-6-123] Identification of characteristics in veterans who often have PTSD and increased SDB is necessary to develop novel veteran-centric treatment approaches.[@b17-nss-6-123]
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###### 

Description of the clinical sample (N=48 subjects)

  Demographics                   Mean   Standard deviation   Minimum   Maximum
  ------------------------------ ------ -------------------- --------- ---------
  Age at initial visit (years)   60.9   4.3                  55        78
  Education (years)              14.3   2.2                  8.0       18.0
  Number of years with PTSD      32.7   11.6                 3.0       59.0

**Abbreviation:** PTSD, post-traumatic stress disorder.

###### 

Mean, standard deviation, and standard error of respiratory, BMI, and cognitive measures (N=48 subjects)

  Measure                          Year 0   Year 1   Year 2   Year 3
  -------------------------------- -------- -------- -------- --------
  AHI                                                         
   Mean                            18.7     21.2     25.4     24.7
   Standard deviation              15.7     19.0     21.2     17.4
   Standard error                  2.3      2.7      3.1      2.5
   Minimum                         0.9      0.7      0.6      0.9
   Maximum                         87.0     80.9     96.0     77.3
  Mean SpO~2~                                                 
   Mean                            93.9     94.0     93.9     93.9
   Standard deviation              1.7      2.1      1.8      1.6
   Standard error                  0.2      0.3      0.3      0.2
   Minimum                         90.0     87.0     89.0     90.0
   Maximum                         97.0     98.0     97.0     97.0
  BMI                                                         
   Mean                            29.5     29.6     29.7     29.8
   Standard deviation              5.1      5.5      5.3      5.7
   Standard error                  0.7      0.8      0.8      0.8
   Minimum                         19.9     19.2     20.5     19.4
   Maximum                         42.1     44.8     42.1     44.1
  RAVLT trials I-V (total score)                              
   Mean                            40.7     40.7     40.8     40.3
   Standard deviation              10.9     10.7     10.7     8.8
   Standard error                  1.6      1.5      1.5      1.3
   Minimum                         20       17       19       19
   Maximum                         67       67       58       62
  CWIT time (seconds)                                         
   Mean                            37.3     36.4     37.6     36.3
   Standard deviation              16.5     16.5     24.6     22.7
   Standard error                  2.4      2.4      3.5      3.3
   Minimum                         2.0      14.0     17.5     11.0
   Maximum                         80.5     82.5     145.0    151.5

**Abbreviations:** AHI, Apnea-Hypopnea Index; BMI, body mass index; SpO~2~, pulse oximeter oxygen saturation; RAVLT, Rey Auditory Verbal Learning Test; CWIT, Color-Word Interference Test.
